menu
    • menu

    Company profile for Confo Therapeutics

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Confo Therapeutics is a drug discovery company building a unique pipeline of GPCR targeted therapeutics addressing unmet medical need. The company was founded in 2015 as a spin-off from the Vrije Universiteit Brussel and VIB and capitalizes on the CONFO® body technology developed by Prof. Jan Steyaert at VIB Structural Biology Research Center, Vrije Universiteit Brussel.Confobodies are camel single domain antibodies that stab...
    Confo Therapeutics is a drug discovery company building a unique pipeline of GPCR targeted therapeutics addressing unmet medical need. The company was founded in 2015 as a spin-off from the Vrije Universiteit Brussel and VIB and capitalizes on the CONFO® body technology developed by Prof. Jan Steyaert at VIB Structural Biology Research Center, Vrije Universiteit Brussel.Confobodies are camel single domain antibodies that stabilize distinct druggable conformers of flexible protein targets and reveal previously inaccessible structural features.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Confo TherapeuticsBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Pleinlaan 2 Building E, 7th Floor, Room E7.6 1050 Brussels
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.confotherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/confo-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Confo Therapeutics Nominates CFTX-2034 for Post-Bariatric Surgery
    Confo Therapeutics Nominates CFTX-2034 for Post-Bariatric Surgery

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207501/0/en/Confo-Therapeutics-Nominates-SSTR5-Agonist-Antibody-CFTX-2034-as-Development-Candidate-for-Post-Bariatric-Hypoglycemia.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Confo Wins VLAIO Grant For Long-Acting GPCR Drugs
    Confo Wins VLAIO Grant For Long-Acting GPCR Drugs

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163128/0/en/Confo-Therapeutics-Awarded-VLAIO-Grant-for-Development-of-Ultra-Long-Acting-Antibody-Based-GPCR-Therapeutics-in-Endocrine-and-Metabolic-Conditions.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Confo Therapeutics Publishes First Structure Of Antibody-GPCR Complex
    Confo Therapeutics Publishes First Structure Of Antibody-GPCR Complex

    01 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241001610010/en

    BUSINESSWIRE
    01 Oct 2024
    Share Share
    Confo Therapeutics Raises 60M EUR In Series B For GPCR Therapies
    Confo Therapeutics Raises 60M EUR In Series B For GPCR Therapies

    25 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240725025121/en

    BUSINESSWIRE
    25 Jul 2024
    Share Share
    Confo Secures VLAIO Grant Supporting Drug Discovery in Endocrine and MD
    Confo Secures VLAIO Grant Supporting Drug Discovery in Endocrine and MD

    28 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240328537717/en

    BUSINESSWIRE
    28 Mar 2024
    Share Share
    Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
    Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer

    12 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230912857351/en

    BUSINESSWIRE
    12 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search